Prospective Assessment for Prediabetes and New-Onset Diabetes in High-Risk Individuals Undergoing Pancreatic Cancer Screening

Gastroenterology. 2021 Nov;161(5):1689-1691.e1. doi: 10.1053/j.gastro.2021.06.055. Epub 2021 Jun 24.

Authors

Ishani Shah¹, Vaibhav Wadhwa¹, Mohammad Bilal¹, Katharine A Germansky¹, Mandeep S Sawhney²; Pancreas Cancer Screening Study Group¹

Collaborators

Pancreas Cancer Screening Study Group:
J Mlabasati, C Kandasamy, D C Huang, A Silva-Santisteban, T M Berzin, D K Pleskow

Affiliations

¹ Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
² Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. Electronic address: msawhney@bidmc.harvard.edu.

PMID: 34175285
DOI: 10.1053/j.gastro.2021.06.055

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers / blood
Blood Glucose / analysis*
Diabetes Mellitus / blood
Diabetes Mellitus / diagnosis*
Diabetes Mellitus / epidemiology
Early Detection of Cancer*
Endosonography*
Fasting / blood
Female
Humans
Incidence
Male
Middle Aged
Pancreatic Neoplasms / diagnostic imaging*
Pancreatic Neoplasms / epidemiology
Prediabetic State / blood
Prediabetic State / diagnosis*
Prediabetic State / epidemiology
Predictive Value of Tests
Prospective Studies
Risk Assessment
Risk Factors

Substances

Biomarkers
Blood Glucose